17 Dec 2019 | Press Releases
To accelerate evelopment of molecular targeted systemic radiotherapy (SR, PRRT) based on its clinical stage technology Edinburgh, United Kingdom – 17 December 2019 – Edinburgh Molecular Imaging Ltd, a company developing theragnostic agents targeting cancer, today...
8 Nov 2018 | Corporate, Press Releases
Seasoned CEO with 30 years’ experience in the healthcare industry Edinburgh, United Kingdom – 8 November 2018 – Edinburgh Molecular Imaging (EM Imaging), the optical molecular imaging company, today announces the appointment of Dr Bernhard Sixt as Chief...
29 Oct 2018 | Corporate, Press Releases
EDINBURGH, Scotland, October 29, 2018 – Roy Davis appointed as Non-Executive Chairman – Current Chair John Jeans to continue as Non-Executive Director Edinburgh Molecular Imaging Ltd (EM Imaging), the clinical phase biotechnology company focused on...
21 Mar 2018 | Collaborations
Bowel Cancer UK and Beating Bowel Cancer announced as Edinburgh Molecular (EM) Imaging’s Charity partner. EM Imaging, based in Edinburgh, is partnering with Bowel Cancer UK and Beating Bowel Cancer to raise funds for the charity and increase awareness of Scotland’s...
2 Jun 2017 | Collaborations
Edinburgh Molecular Imaging is proud to support the University of Edinburgh team.The researchers aim to create new chemicals – known as tracers – to illuminate these unstable plaques in patients. The tracers – which contain small amounts of radioactivity – are...
7 Oct 2016 | Awards, Events
OBN Awards 2016 Winners Recognised at Industry Leading Event EM Imaging CEO Ian Wilson celebrates wining the Best Emerging Medtech Company Award at OBN 2016. At the OBN Awards 2016 dinner in Oxford last night, Edinburgh Molecular Imaging were awarded the Best...
